RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
Decentralized Clinical Trials for Rare Disease Treatments
Decentralized clinical trials offer the potential to democratize rare disease research, advancing drug development and improving patient experiences.
Use of Patient-Centered Outcomes in ICER Assessments
Avalere assessed the current use of patient-centered outcomes in ICER evidence reports and determined the patient voice minimally influences modeling results.
How Can Patients and Caregivers Participate in Negotiation?
Recently released guidance and a second draft Negotiation Data Elements ICR introduce several opportunities for patients and caregivers to shape negotiation.
Implementation Science Integrates Evidence into Care
Despite proven benefits, evidence-based interventions are rarely adopted. Implementation science can support the integration of such interventions in routine healthcare.
US Makes Majority of API by Dollar Value in US-Consumed Medicines
Data analysis finds that 53% of the API, in dollars, used in domestically consumed medicines came from the US in 2021, and 85% came from the US or Europe.
ISPOR 2023 Presentation: The Future of Value and Evidence Strategy
Avalere’s expert presentations at ISPOR described the IRA’s impact on evidence strategy and highlighted a recent study to capture total disease burden.
What’s Next for Patient-Centered Value?
A significant push towards patient-centered value has occurred in recent years, yet a validated instrument to collect patient-centered data has not been established. The Patient Perspective Value Framework (PPVF) Initiative offers an approach for addressing this missing piece.
Infusing the Patient Perspective into Value Assessment
Current value assessment methods do not effectively and quantitatively include patients’ perspectives in the evaluation of treatment value.
Survey Finds 58% of Payers Use Outcomes-Based Contracts
In 2022, over half of payers had at least one outcomes-based contract (OBC) and used claims-based outcomes, despite acknowledging the limitations of using claims to measure clinical benefit.
RWE Considerations Throughout Product Development Cycle
Drug manufacturers can use real-world evidence (RWE) before and after approval to advance product development and adoption.
Video: The Future of Patient-Centric Value
Avalere experts Amanda Napoles and Shelby Harrington share recommendations for shifting to patient-centered value during our 2023 Outlook webinar.
Patient- and Caregiver-Centered Value in Rare Disease Treatment
Traditional health technology assessments fall short in accounting for how therapy addresses the total burden of illness experienced by affected individuals.
Video: Patient-Centered Value Frameworks
Avalere experts will discuss patient-centric value frameworks, their utility to different stakeholders, and how they can drive the transformation to a patient-centered, equitable health system at the AMCP Nexus 2022 conference.
Patient–Provider Collaboration: Shared Decision Making in Cancer Care
In the latest installment of Avalere’s ongoing insight series about shared decision making, Michelle Bruno, Associate Principal in Avalere’s Center for Healthcare Transformation, describes the role it can play in cancer care.
Avalere Expands Data and Analytics Focus with New Addition
Avalere Health welcomes Mandar Karhade, who supports healthcare outcomes research and data commercialization through innovation and advanced technology.
Shared Decision Making: An Insight Series on Clinician-Patient Collaboration Improving Engagement & Outcomes
A new series explores how shared decision-making can be applied in multiple therapeutic areas to reach patient, clinician, and other stakeholders’ goals.
Medicare Beneficiary Care Differences by Practice Ownership
Avalere released a white paper analyzing spending and utilization among Medicare beneficiaries receiving care from independent physician practices and hospital-owned physician practices in Ohio.
Alex Du Joins Avalere Health’s Market Access Practice
Avalere Health welcomes Alex (Shuang) Du as an associate principal to its Market Access practice. He will support a variety of Avalere’s clients in navigating the evolving healthcare landscape.
Majority of API in US-Consumed Medicines Is Produced in the US
Analysis of the most recent available trade data finds that 53% of API, in dollars, used in domestically consumed medicines came from the US in 2020.
Treating Depression Reduces Medicare Costs; Provider Challenges Remain
A recent Avalere analysis of Medicare Fee-for-Service (FFS) data illustrates that treating major depressive disorder (MDD) in Medicare-eligible beneficiaries results in a 4% reduction in total cost compared to untreated patients, highlighting the importance of incentivizing adequate provider supply and payment in the geriatric psychiatry market.